Results 81 to 90 of about 1,617 (203)

Chronic kidney disease and valvular heart disease: State of the art

Physiological Reports, Volume 13, Issue 18, September 2025.
Abstract Chronic kidney disease (CKD) and valvular heart disease (VHD) frequently coexist and are associated with a significant increase in morbidity and mortality. Their interplay is complex and multifactorial, involving shared pathophysiological mechanisms such as chronic inflammation, mineral and bone disorder, vascular and valvular calcification ...
S. Saltarocchi, M. D'Abramo, P. De Orchi, F. Spunticchia, M. Totaro, E. M. Cirio, F. Miraldi   +6 more
wiley   +1 more source

A More Efficient Method of Patient Evaluation for TMVR: Planning for Best- and Worst-Case Position [PDF]

, 2019
Background: Left ventricular outflow tract (LVOT) obstruction is a life-threatening complication after transcatheter mitral valve replacement (TMVR), occurring in ∼10% of patients.
Schrot, J, Wang, Dee Dee, Rollet, Marianne, Kubiak, Kati, Ward, C   +4 more
core  

Emergent Cardiac Surgery After Transcatheter Structural Heart Procedures: Narrative Review

Catheterization and Cardiovascular Interventions, Volume 106, Issue 1, Page 136-143, July 1, 2025.
ABSTRACT Transcatheter structural heart procedures have become standard therapy for elderly patients with high surgical risk. Over time, these procedures have significantly increased worldwide, accompanied by a concomitant reduction of major complications, including those requiring emergent cardiac surgery (ECS).
Miriam Compagnone, Gianni Dall'Ara, Simone Grotti, Daniela Spartà, Giuseppe Guerrieri, Carmine Pizzi, Fabio Felice Tarantino, Marcello Galvani   +7 more
wiley   +1 more source

Influence of the ratio of mean arterial pressure to right atrial pressure on outcome after successful percutaneous edge-to-edge repair for severe mitral valve regurgitation

International Journal of Cardiology: Heart & Vasculature, 2021
Background: It is important to identify further predictors of outcome after successful transcatheter mitral valve repair (TMVR), as optimal patient selection remains difficult. Objective: The study investigates the prognostic benefit of the mean arterial
Rico Osteresch, Kathrin Diehl, Patrick Dierks, Johannes Schmucker, Azza Ben Ammar, Luis Alberto Mata Marin, Andreas Fach, Christian Frerker, Ingo Eitel, Rainer Hambrecht, Harm Wienbergen   +10 more
doaj   +1 more source

Experimental validation of TMVR technologies: a bumpy road with the risk of getting lost in translation [PDF]

EuroIntervention, 2017
n ...
Latib, Azeem, Granada, Juan
openaire   +2 more sources

First Experience With a Novel Self‐Expandable Valve for Mitral Annular Calcification Guided by Three‐Dimensional Printing

Catheterization and Cardiovascular Interventions, Volume 105, Issue 4, Page 855-860, March 1, 2025.
ABSTRACT Transcatheter mitral valve replacement (TMVR) may emerge as a surgical alternative for high‐risk patients with severe mitral annular calcification (MAC), yet several questions remain to be addressed. We present the case of a 67‐year‐old high‐risk female patient with severe MAC (MAC score = 8) and mitral stenosis (effective orifice area = 121.3 
Yiwei Wang, Yuliang Ma, Yang Liu, Jian Yang   +3 more
wiley   +1 more source

Impact of Rhythm vs. Rate Control in Atrial Fibrillation on the Long-Term Outcome of Patients Undergoing Transcatheter Edge-to-Edge Mitral Valve Repair [PDF]

, 2021
Atrial fibrillation (AF) is a highly prevalent comorbidity in patients with severe mitral valve regurgitation (MR) undergoing transcatheter mitral valve repair (TMVR) and has been shown to significantly worsen their outcome.
Juan Cheko, Ulrich Luesebrink, Georgios Chatzis, Christian Waechter, Hans-Helge Mueller, Thomas Deneke, Sebastian Barth, Jan Kikec, Dimitar Divchev, Dieter Fischer, Holger Nef, Philipp Halbfass, Felix Ausbuettel, Sebastian Kerber, Bernhard Schieffer   +14 more
core   +1 more source

2024 update in heart failure

ESC Heart Failure, Volume 12, Issue 1, Page 8-42, February 2025.
Abstract In the last years, major progress has occurred in heart failure (HF) management. The 2023 ESC focused update of the 2021 HF guidelines introduced new key recommendations based on the results of the last years of science. First, two drugs, sodium–glucose co‐transporter‐2 (SGLT2) inhibitors and finerenone, a novel nonsteroidal, selective ...
Alberto Beghini, Antonio Maria Sammartino, Zoltán Papp, Stephan von Haehling, Jan Biegus, Piotr Ponikowski, Marianna Adamo, Luigi Falco, Carlo Mario Lombardi, Matteo Pagnesi, Gianluigi Savarese, Marco Metra, Daniela Tomasoni   +12 more
wiley   +1 more source

Advances in Transcatheter Mitral Valve Replacement (TMVR) in Patients with Mitral Annular Calcification: A Case Report of Acute Hemolytic Anemia and Review of Contemporary Approaches [PDF]

Mitral valve disease, particularly in the context of extensive mitral annular calcification (MAC), poses significant challenges for traditional surgical management.
Umang Makhijani, Nivetha Vajayakumar, Micaela Iantorno, Natalia Fongrat, Andrew Mangano   +4 more
core   +1 more source

Accuracy of Three‐Dimensional Neo Left Ventricular Outflow Tract Simulations With Transcatheter Mitral Valve Replacement in Different Mitral Phenotypes

Catheterization and Cardiovascular Interventions, Volume 105, Issue 1, Page 249-257, January 1, 2025.
ABSTRACT Background Transcatheter mitral valve replacement (TMVR) is emerging in the context of annular calcification (valve‐in‐MAC; ViMAC), failing surgical mitral annuloplasty (mitral‐valve‐in‐ring; MViR) and failing mitral bioprosthesis (mitral‐valve‐in‐valve; MViV).
Mark M. P. van den Dorpel, Lucas Uchoa de Assis, Jenna van Niekerk, Rutger‐Jan Nuis, Joost Daemen, Claire Ben Ren, Alexander Hirsch, Isabella Kardys, Ben J. L. van den Branden, Ricardo Budde, Nicolas M. Van Mieghem   +10 more
wiley   +1 more source